{"id":30426,"date":"2016-09-23T21:32:08","date_gmt":"2016-09-24T04:32:08","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/09\/synthetic-biology-competition-launched"},"modified":"2017-04-24T19:36:52","modified_gmt":"2017-04-25T02:36:52","slug":"synthetic-biology-competition-launched","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/09\/synthetic-biology-competition-launched","title":{"rendered":"Synthetic biology competition launched"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/synthetic-biology-competition-launched.jpg\"><\/a><\/p>\n<p>An annual competition has been launched to assist companies aiming to solve world issues with synthetic biology.<\/p>\n<p>Bio-start offers the winner a combination of \u00a3100k cash as well as laboratory space, professional services and a 10 week accelerator programme with mentorship valued at approximately \u00a3100k.<\/p>\n<p>Dr Stephen Chambers, CEO of SynbiCITE, one of the companies involved in the founding of the competition said: \u201cThis is a first in the UK for synthetic biology and our aim is to help as many companies and entrepreneurs as we can. Once applications have been assessed up to twenty-five businesses will go through our ten-week boot-camp and mentoring programme. Up to ten will go through to the final awards evening where they\u2019ll have a chance to pitch their ideas to an expert panel in front of an audience of investors and industry leaders.\u201d<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.labnews.co.uk\/news\/synthetic-biology-competition-launched-23-09-2016\/\">http:\/\/www.labnews.co.uk\/news\/synthetic-biology-competition-...&#45;2016\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An annual competition has been launched to assist companies aiming to solve world issues with synthetic biology. Bio-start offers the winner a combination of \u00a3100k cash as well as laboratory space, professional services and a 10 week accelerator programme with mentorship valued at approximately \u00a3100k. Dr Stephen Chambers, CEO of SynbiCITE, one of the companies [\u2026]<\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,3],"tags":[],"class_list":["post-30426","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biological"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/30426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=30426"}],"version-history":[{"count":3,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/30426\/revisions"}],"predecessor-version":[{"id":49831,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/30426\/revisions\/49831"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=30426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=30426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=30426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}